We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · May 10, 2021

Magnetic Sphincter Augmentation and Transoral Incisionless Fundoplication in Refractory GERD

Endoscopy international open

 

Additional Info

Endoscopy international open
Clinical Efficacy and Safety of Magnetic Sphincter Augmentation (MSA) and Transoral Incisionless Fundoplication (TIF2) in Refractory Gastroesophageal Reflux Disease (GERD): A Systematic Review and Meta-Analysis
Endosc Int Open 2021 Apr 01;9(4)E583-E598, S Chandan, BP Mohan, SR Khan, LK Jha, AJ Dhaliwal, M Bilal, M Aziz, A Canakis, S Arora, S Malik, LL Kassab, S Ponnada, I Bhat, AT Hewlett, N Sharma, S McDonough, DG Adler

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.